Alan Landay to Time Factors
This is a "connection" page, showing publications Alan Landay has written about Time Factors.
Connection Strength
0.328
-
The Hitchhiker Guide to CD4+ T-Cell Depletion in Lentiviral Infection. A Critical Review of the Dynamics of the CD4+ T Cells in SIV and HIV Infection. Front Immunol. 2021; 12:695674.
Score: 0.037
-
Nonclassical Monocytes (CD14dimCD16+) Are Associated With Carotid Intima-Media Thickness Progression for Men but Not Women: The Multi-Ethnic Study of Atherosclerosis-Brief Report. Arterioscler Thromb Vasc Biol. 2021 05 05; 41(5):1810-1817.
Score: 0.036
-
Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease. AIDS. 2000 May 05; 14(7):761-70.
Score: 0.034
-
Vitamin D does not modulate immune-mediated bone loss during ART initiation. Antivir Ther. 2019; 24(5):355-362.
Score: 0.031
-
Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS. 1998 Jul 30; 12(11):F123-9.
Score: 0.030
-
Association of HIV clinical disease progression with profiles of early immune activation: results from a cluster analysis approach. AIDS. 2013 Jun 01; 27(9):1473-81.
Score: 0.021
-
Association of subclinical atherosclerosis with lipid levels amongst antiretroviral-treated and untreated HIV-infected women in the Women's Interagency HIV study. Atherosclerosis. 2012 Dec; 225(2):408-11.
Score: 0.020
-
Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates. Blood. 2012 Aug 16; 120(7):1357-66.
Score: 0.020
-
Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks. AIDS Res Hum Retroviruses. 2012 Oct; 28(10):1184-95.
Score: 0.019
-
Flow cytometric monitoring of human immunodeficiency virus-infected patients. Simultaneous enumeration of five lymphocyte subsets. Am J Clin Pathol. 1989 Dec; 92(6):721-8.
Score: 0.016
-
Effect of mucosal fluid from women with bacterial vaginosis on HIV trans-infection mediated by dendritic cells. Virology. 2009 Mar 01; 385(1):22-7.
Score: 0.015
-
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328. Arch Intern Med. 2007 Mar 26; 167(6):597-605.
Score: 0.014
-
Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells. AIDS. 2007 Jan 30; 21(3):293-305.
Score: 0.013
-
Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol. 1998 Aug; 153(2):481-90.
Score: 0.007
-
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. J Infect Dis. 1998 Jul; 178(1):70-9.
Score: 0.007
-
Changes in total, CD4+, and CD8+ lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women. The Women and Infants Transmission Study. Obstet Gynecol. 1997 Jun; 89(6):967-74.
Score: 0.007